SHARI RHODES: Open Payments
NPI 1083125538 · ADA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 23 payments from 8 companies in 2025. Trend: 2023 $447 · 2024 $568 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $158 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Corcept Therapeutics | 2 | $42 |
| ABBVIE INC. | 2 | $31 |
| Antares Pharma, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: Ozempic, Rybelsus, Korlym, FARXIGA, AIRSUPRA, VRAYLAR, Saxenda, XYOSTED.
Industry payments across OK — which companies pay providers there.
